FWM
VIRX

Frontier Wealth Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Frontier Wealth Management’s Portfolio VIRX Stock Details VIRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
2016
Q3 		$583K Buy
2016
Q2 		$259K Sell
2016
Q1 		$264K Sell
2015
Q4 		$474K Sell
2015
Q3 		$449K Buy
2015
Q2 		$1.03M Buy